Gastric electrical stimulation improves glycaemic control and weight loss among obese patients with type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Comparison of orlistat treatment and placebo in obese type 2 diabetic patients

By Derosa Giuseppe   Maffioli Pamela   Salvadeo Sibilla AT   Ferrari Ilaria   Gravina Alessia   Mereu Roberto   D'Angelo Angela   Fogari Elena   Palumbo Ilaria   Randazzo Sabrina   Cicero Arrigo FG  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 1971-1982

Informa Healthcare

Access to resources Recommend Favorite

A Possible Link of Gut Microbiota Alteration in Type 2 Diabetes and Alzheimer’s Disease Pathogenicity: An Update

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 3, 2014-04 ,pp. : 383-390

Bentham Science Publishers

Access to resources Recommend Favorite

Bromocriptine improves glycaemic control and serum lipid profile in obese Type 2 diabetic subjects: a new approach in the treatment of diabetes

By Cincotta A.H.   Meier A.H.   Cincotta M.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 10, 1999-10 ,pp. : 1683-1707

Informa Healthcare

Access to resources Recommend Favorite

Investigation of Chitosan for Prevention of Diabetic Progression Through Gut Microbiota Alteration in Sugar Rich Diet Induced Diabetic Rats

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 2, 2016-02 ,pp. : 173-184

Bentham Science Publishers

Access to resources Recommend Favorite